Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.

Martin j. Van den bent; Sara Erridge; Michael a. Vogelbaum; Anna k. Nowak; Marc Sanson; Alba ariela Brandes; Wolfgang Wick; Paul m. Clement; Jean-Francois Baurain; Warren p. Mason; Helen Wheeler; Michael Weller; Kenneth d. Aldape; Pieter Wesseling; Johan m. Kros; Mircea Tesileanu; Vassilis Golfinopoulos; Thierry Gorlia; Brigitta g. Baumert; Pim French

doi:10.1200/JCO.2019.37.15_suppl.2000

Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.

Martin j. Van den bent
, Sara Erridge
, Michael a. Vogelbaum
, Anna k. Nowak
, Marc Sanson
, Alba ariela Brandes
, Wolfgang Wick
, Paul m. Clement
, Jean-Francois Baurain
, Warren p. Mason
, Helen Wheeler
, Michael Weller
, Kenneth d. Aldape
, Pieter Wesseling
, Johan m. Kros
, Mircea Tesileanu
, Vassilis Golfinopoulos
, Thierry Gorlia
, Brigitta g. Baumert
, Pim French

School of Population Health Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	2000-2000
Journal	Journal of Clinical Oncology
Volume	37
Issue number	15_suppl
DOIs	https://doi.org/10.1200/JCO.2019.37.15_suppl.2000
Publication status	Published - 20 May 2019

Access to Document

10.1200/JCO.2019.37.15_suppl.2000

http://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.2000

Cite this

Van den bent, M. J., Erridge, S., Vogelbaum, M. A., Nowak, A. K., Sanson, M., Brandes, A. A., Wick, W., Clement, P. M., Baurain, J.-F., Mason, W. P., Wheeler, H., Weller, M., Aldape, K. D., Wesseling, P., Kros, J. M., Tesileanu, M., Golfinopoulos, V., Gorlia, T., Baumert, B. G., & French, P. (2019). Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion. Journal of Clinical Oncology, 37(15_suppl), 2000-2000. https://doi.org/10.1200/JCO.2019.37.15_suppl.2000

@article{54125698f9bf4fe78d2e17dcf9cf9551,

title = "Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.",

author = "\{Van den bent\}, \{Martin j.\} and Sara Erridge and Vogelbaum, \{Michael a.\} and Nowak, \{Anna k.\} and Marc Sanson and Brandes, \{Alba ariela\} and Wolfgang Wick and Clement, \{Paul m.\} and Jean-Francois Baurain and Mason, \{Warren p.\} and Helen Wheeler and Michael Weller and Aldape, \{Kenneth d.\} and Pieter Wesseling and Kros, \{Johan m.\} and Mircea Tesileanu and Vassilis Golfinopoulos and Thierry Gorlia and Baumert, \{Brigitta g.\} and Pim French",

year = "2019",

month = may,

day = "20",

doi = "10.1200/JCO.2019.37.15\_suppl.2000",

language = "English",

volume = "37",

pages = "2000--2000",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15\_suppl",

}

Van den bent, MJ, Erridge, S, Vogelbaum, MA, Nowak, AK, Sanson, M, Brandes, AA, Wick, W, Clement, PM, Baurain, J-F, Mason, WP, Wheeler, H, Weller, M, Aldape, KD, Wesseling, P, Kros, JM, Tesileanu, M, Golfinopoulos, V, Gorlia, T, Baumert, BG & French, P 2019, 'Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.', Journal of Clinical Oncology, vol. 37, no. 15_suppl, pp. 2000-2000. https://doi.org/10.1200/JCO.2019.37.15_suppl.2000

Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion. / Van den bent, Martin j.; Erridge, Sara; Vogelbaum, Michael a. et al.
In: Journal of Clinical Oncology, Vol. 37, No. 15_suppl, 20.05.2019, p. 2000-2000.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.

AU - Van den bent, Martin j.

AU - Erridge, Sara

AU - Vogelbaum, Michael a.

AU - Nowak, Anna k.

AU - Sanson, Marc

AU - Brandes, Alba ariela

AU - Wick, Wolfgang

AU - Clement, Paul m.

AU - Baurain, Jean-Francois

AU - Mason, Warren p.

AU - Wheeler, Helen

AU - Weller, Michael

AU - Aldape, Kenneth d.

AU - Wesseling, Pieter

AU - Kros, Johan m.

AU - Tesileanu, Mircea

AU - Golfinopoulos, Vassilis

AU - Gorlia, Thierry

AU - Baumert, Brigitta g.

AU - French, Pim

PY - 2019/5/20

Y1 - 2019/5/20

U2 - 10.1200/JCO.2019.37.15_suppl.2000

DO - 10.1200/JCO.2019.37.15_suppl.2000

M3 - Meeting abstract

SN - 0732-183X

VL - 37

SP - 2000

EP - 2000

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15_suppl

ER -

Van den bent MJ, Erridge S, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA et al. Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion. Journal of Clinical Oncology. 2019 May 20;37(15_suppl):2000-2000. doi: 10.1200/JCO.2019.37.15_suppl.2000